FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to accomplish the goals of its Safe Use Initiative through a combination of voluntary moves by industry and regulatory activities
You may also be interested in...
Acetaminophen Overdose Risk Persists Despite Label Changes – Study
Many consumers do not closely read OTC painkiller labels and often do not adhere to package or label instructions, researchers say. Many likely are unaware of or ignore label changes industry voluntarily made and FDA ordered to reduce the risk of liver toxicity due to unintentional overdose.
Acetaminophen Overdose Risk Persists Despite Label Changes – Study
Many consumers do not closely read OTC painkiller labels and often do not adhere to package or label instructions, researchers say. Many likely are unaware of or ignore label changes industry voluntarily made and FDA ordered to reduce the risk of liver toxicity due to unintentional overdose.
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports
FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.